Verapamil, an antagonist at 5-Hydroxytryptamine receptors of human blood platelets
- 1 January 1985
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 108 (2) , 157-162
- https://doi.org/10.1016/0014-2999(85)90720-4
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Contamination of serotonin-2 binding sites by an alpha-1 adrenergic component in assays with (3H) spiperoneLife Sciences, 1984
- Effects of verapamil on platelet aggregation, ATP release and thromboxane generationThrombosis Research, 1983
- The effects of nifedipine, a calcium antagonist, on platelet functionAmerican Heart Journal, 1983
- Does the organic calcium channel blocker D600 act from inside or outside on the cardiac cell membrane?Pflügers Archiv - European Journal of Physiology, 1982
- PY 108–068, a New, Potent, and Selective Inhibitor of Calcium-Induced Contraction of Rabbit Aortic RingsJournal of Cardiovascular Pharmacology, 1982
- A nonlinear regression program for small computersAnalytical Biochemistry, 1981
- Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazemThe American Journal of Cardiology, 1980
- The involvement of calcium in epinephrine or ADP potentiation of human platelet aggregationThrombosis Research, 1980
- Serotonergic component of neuroleptic receptorsNature, 1978
- Direct evidence for intracellular divalent cation redistribution associated with platelet shape changeBiochemical and Biophysical Research Communications, 1976